Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
null
Evogene Ltd (EVGN) Q1 2026 Earnings Call Highlights: Strategic Collaborations Amid Financial ...
null
Evogene Reports First Quarter 2026 Financial Results
null
Evogene Ltd. Q1 2026 Earnings Call Summary
null
Evogene Shares Decline After Revenue Miss Despite Stronger-Than-Expected Earnings (EVGN)
null
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small...
null
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small...
null
Evogene to Present at the 24th Schrödinger European User Group Meeting
null
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small...
null
Evogene Schedules First Quarter 2026 Financial Results Release
null
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
null
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
null
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
null
Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline
null
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small...
null
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
null
Evogene Ltd. Q4 2025 Earnings Call Summary
null
Evogene: Q4 Earnings Snapshot
undefined
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small...
null
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
#Partners
Evogene Releases CEO Letter to Shareholders
#Partners #Product Stage
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative AI design of small...
#Partners #Acquired-by
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
undefined
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
#Partners
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules...
undefined
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules...
#Partners
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases
#Partners #Product Stage
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™
#Partners
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a computational chemistry company focused on AI-driven small-molecule design for the pharmaceutical...
#Partners
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene" or the "Company"), a pioneering computational chemistry company, specializing in the...
#PIPE
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
#PIPE
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the AI-driven discovery and design of novel...
#Management Changes
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board
#Management Changes
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
#Product Stage #Partners
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
#Product Stage #Partners
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
#Partners
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company, specializing in the generative design of small...
#Partners
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development
#Management Changes
Evogene: Q3 Earnings Snapshot
undefined
Evogene Reports Third Quarter 2025 Financial Results
#Acquired-by #Acquisition #Layoffs
Conference call and webcast: today, November 20, 2025, 9:00 AM ET Financial Highlights: During the first nine months ending September 30, 2025, Evogene...
#Acquired-by #Acquisition #Layoffs
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
#Partners
Evogene Schedules Third Quarter 2025 Financial Results Release
undefined
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
undefined
Evogene Declares The Sale Of Lavie Bio’s Activity To ICL Completed
#Acquisition
Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...
#Layoffs #Investment #Partners #Acquisition
Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie Bio, a...
#Acquisition #Investment #Layoffs #Partners #Customers
Evogene: Q2 Earnings Snapshot
undefined
Evogene Reports Second Quarter 2025 Financial Results
#Acquired-by #Layoffs
/PRNewswire/ -- Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology and chemistry company, today announced a scientific collaboration with the...
undefined
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
#Partners
Evogene Schedules Second Quarter 2025 Financial Results Release
undefined
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
undefined
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
#Acquired-by
Agricultural Biotechnology Market Outlook Report to 2030, with Profiles of Bayer, Corteva, Syngenta, BASF, FMC, Bioceres Crop Solutions, Evogene, Marrone Bio Innovations, Calyxt & Arcadia Biosciences
undefined
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and...
#Partners #Product Stage
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
undefined
Evogene Ltd (EVGN) Q1 2025 Earnings Call Highlights: Strategic Expense Reductions and Promising ...
#Acquisition #Product Stage #Partners #Customers
Evogene Reports First Quarter 2025 Financial Results
#Acquisition #Customers
Evogene: Q1 Earnings Snapshot
undefined
Conference call and webcast: today, May 21, 2025, 9:00 am ET Financial Highlights: In the first quarter of 2025, total revenues were approximately $2.4...
#Acquisition #Product Stage #Investment #Partners #Customers
Evogene Schedules First Quarter 2025 Financial Results Release
undefined
Why Evogene Ltd. (EVGN) Soared on Monday
#Acquisition
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
#Acquired-by #Partners
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product...
#Acquired-by #Partners
אבוג'ן מוכרת לאיי.סי.אל פעילות פיתוח של מאיצי צמיחה ב-18 מיליון דולר
#Acquisition
Evogene Ltd (EVGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
#Customers #Partners #Layoffs
Evogene: Q4 Earnings Snapshot
undefined
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
#Management Changes
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery...
#Management Changes
Conference call and webcast: today, March 6, 2025, 9:00 am ET Financial Highlights: In the year 2024, total revenues reached approximately $8.5 million...
#Customers #Partners #Investment #Management Changes #Layoffs
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results
#Customers #Partners #Layoffs
Evogene Schedules Fourth Quarter 2024 Financial Results Release
undefined
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
undefined
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease
#Product Stage #Partners
Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities
#Investment #Partners
Evogene: Q3 Earnings Snapshot
undefined
Evogene Reports Third Quarter 2024 Financial Results
#Investment #Layoffs
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
#Customers #Partners
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials
#Customers #Expand
Evogene Schedules Third Quarter 2024 Financial Results Release
undefined
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
#Partners
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery...
#Partners
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
#Customers
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
#Partners
/PRNewswire/ -- Watershed AC ("Watershed", formerly Colors Farm Ltd.), a cutting-edge company in sustainable aquaculture and biotech and Evogene Ltd....
#Partners
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
#Investment
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
#Investment
Evogene Reports Second Quarter 2024 Financial Results
#Customers #Partners #Management Changes
Evogene: Q2 Earnings Snapshot
#Layoffs
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
#Public Trading
Evogene Schedules Second Quarter 2024 Financial Results Release
#Management Changes
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil
#Customers
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
#Public Trading
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
#Partners
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat
#Customers #Expand
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country
#Customers #Expand
Evogene Reports First Quarter 2024 Financial Results
#Customers #Partners #Management Changes #Expand
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
#Investment, Management Changes
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds
#Partners #Expand
Evogene Schedules First Quarter 2024 Financial Results Release
undefined
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
#Investment
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
#Research
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
#Investment #Partners
Evogene Announces Filing of Annual Report on Form 20-F
#Public Trading
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
#Public Trading
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
#Partners #Expand
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
#Partners
Evogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcript
#Customers #Partners #Management Changes #Expand
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
#Customers #Partners #Investment #Expand
Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates
#Investment, Management Changes
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
#Partners #Expand
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties
#Partners #Expand
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
#Partners #Investment
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
undefined
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
#Management Changes
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
#Partners #Investment
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
#Partners
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
#Partners
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
#Management Changes
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
#Customers
Here's Why Evogene (EVGN) is a Great Momentum Stock to Buy
#Investment
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
#Partners
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
#Management Changes #Expand
Is Compugen (CGEN) Outperforming Other Medical Stocks This Year?
#Investment
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
#Partners #Expand
Bears are Losing Control Over Evogene (EVGN), Here's Why It's a 'Buy' Now
#Investment
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley
#Customers #Expand
Evogene Ltd. (NASDAQ:EVGN) Q3 2023 Earnings Call Transcript
#Customers #Partners #Investment #Expand
Evogene Reports Third Quarter 2023 Financial Results
#Customers #Partners #Investment #Expand
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results
#Customers #Expand
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
undefined
Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology
#Partners
Evogene Provides Operational Update Amidst Current Security Situation in Israel
undefined
Casterra Delivers First Shipment of Castor Seeds to Africa
#Customers, Partners
Evogene Ltd. (NASDAQ:EVGN) Q2 2023 Earnings Call Transcript
#Investment #Partners
Evogene (EVGN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
#Customers #Partners
Evogene Reports Second Quarter 2023 Financial Results
#Investment #Partners #Customers
Evogene (EVGN) Reports Q2 Loss, Lags Revenue Estimates
#Customers
Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center
#Customers #Partners
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023
#None
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery
#Customers #Partners #Expand
Biomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) Program
#Partners #Expand
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience
#Partners
Evogene Announces Pricing of US$8,500,000 Registered Direct Offering
#Investment
AgPlenus Appoints Dr. Adrian Percy to Its Board of Directors
#Management Changes
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories
#Customers
TalkMarkets Announces Company Spotlight Featuring Evogene
#Investment #Customers
Casterra Signs a Framework Agreement with a World Leading Oil and Gas Company to Sell Its Castor Seeds for Sustainable Biofuel Production, with Initial Purchase Orders of $9.1 Million
#Customers
Lavie Bio Receives Canadian Regulatory Approval for Thrivus™, Expanding Global Reach
#Customers #Expand
Evogene Reports First Quarter 2023 Financial Results
#Investment #Expand
Evogene (EVGN) Reports Q1 Loss, Misses Revenue Estimates
#Customers
Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant to Develop Oil-Seed Crops with High CO2 Assimilation and Drought Tolerance
#Investment #Partners
Evogene Schedules First Quarter 2023 Financial Results Release & Conference Call for May 18, 2023
#Public Trading
Plantis Licenses Two of Canonic's Proprietary Cannabis Varieties to Expand its Offerings in the Israeli Market
undefined
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
#Investment #Partners #Expand
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital
#Investment
Evogene Announces Filing of Annual Report on Form 20-F
#Public Trading
Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer
#Management Changes
Evogene Offers Stock Investors An Excellent Risk/Reward Ratio
#Investment #Partners
Biomica VP R&D to Present at the Pharmabiotics 2023 Conference on March 21, 2023
#Partners
Evogene Ltd. (NASDAQ:EVGN) Q4 2022 Earnings Call Transcript
undefined
Evogene Reports Fourth Quarter and Full Year 2022 Financial Results
#Investment #Partners #Customers
Evogene (EVGN) Reports Q4 Loss, Tops Revenue Estimates
undefined
Lavie Bio to Host a Round Table Discussion and is a Sponsor at World Agri-Tech Conference in San Francisco
#Partners
AgPlenus to Attend World Agri-Tech Conference in San Francisco
#Partners
Evogene to Attend the Annual ROTH Investor Conference in California on March 13, 2023
#Investment
Biomica CSO to Present at the ECCO 2023 Annual Meeting in Copenhagen between March 1-4, 2023
#Partners
Lavie Bio Reports Successful Results for its Bio-Fungicides Programs
#Customers #Investment
Evogene Schedules Third Quarter of 2022 Financial Results Release & Conference Call for November 17, 2022
undefined
Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles
#Investment #Partners
חברת הגנטיקה החקלאית שממציאה את עצמה מחדש
#Partners, Investment, Management Changes
Evogene Reports Third Quarter 2021 Financial Results
#Management Changes #Investment
Evogene Announces Participation in the Second Research Period of the CRISPR-IL Consortium
#Investment
Evogene Announces Ms. Sarit Firon to become Evogene's Chairperson of the Board
#Management Changes
Evogene Prices $12 Million Registered Direct Offering
#Investment
Evogene (EVGN) Raises $10 Million In Equity Led Investment From ARK And Alpha Capital
#Investment
Evogene teams with Weizmann Nobel laureate on microbiomes
#Partners
Evogene enters medical cannabis sector
#Expand
Genetic Crop Design Company Evogene Sets Up Agricultural Biology Subsidiary
#Partners #Management Changes
Evogene and TMG Announce Collaboration to Develop Nematode Resistant Soybean through Genome Editing
#Partners
Evogene teams with BASF on insecticides
#Partners
Evogene and Marrone Bio Innovations Announce Phase Advancement in their Insect Control Collaboration
#Partners #Investment
Evogene unit Biomica designs molecules to analyze bacteria
#Partners
Evogene and DuPont team to improve corn yields
#Partners
Genetic Crop Design Company Evogene Amends Bayer Collaboration Agreement
#Partners
Evogene reports progress in corn agreement with Monsanto
#Partners #Investment
BRIEF-Evogene and Marrone Bio Innovations disclose positive results in insect control
undefined
http://www.bloomberg.com/news/articles/2016-01-05/insect-beating-seeds-are-growth-engine-for-evogene-ceo-says
#Customers #Partners
Evogene teams with BASF on herbicide development
#Partners
Evogene Develops GMO Tech To Secure The Food Of The Future
#Partners #Investment
Evogene opens new crop protection R&D center
#Expand
Evogene raises $74m in New York
#Investment
Agrotech co EvoGene to raise $10m on TASE
#Investment #Public Trading